178 related articles for article (PubMed ID: 19221507)
1. Viral subversion of immunogenic cell death.
Kepp O; Senovilla L; Galluzzi L; Panaretakis T; Tesniere A; Schlemmer F; Madeo F; Zitvogel L; Kroemer G
Cell Cycle; 2009 Mar; 8(6):860-9. PubMed ID: 19221507
[TBL] [Abstract][Full Text] [Related]
2. Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway.
Zitvogel L; Kepp O; Senovilla L; Menger L; Chaput N; Kroemer G
Clin Cancer Res; 2010 Jun; 16(12):3100-4. PubMed ID: 20421432
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death.
Panaretakis T; Kepp O; Brockmeier U; Tesniere A; Bjorklund AC; Chapman DC; Durchschlag M; Joza N; Pierron G; van Endert P; Yuan J; Zitvogel L; Madeo F; Williams DB; Kroemer G
EMBO J; 2009 Mar; 28(5):578-90. PubMed ID: 19165151
[TBL] [Abstract][Full Text] [Related]
4. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death.
Garg AD; Krysko DV; Verfaillie T; Kaczmarek A; Ferreira GB; Marysael T; Rubio N; Firczuk M; Mathieu C; Roebroek AJ; Annaert W; Golab J; de Witte P; Vandenabeele P; Agostinis P
EMBO J; 2012 Mar; 31(5):1062-79. PubMed ID: 22252128
[TBL] [Abstract][Full Text] [Related]
5. High hydrostatic pressure induces immunogenic cell death in human tumor cells.
Fucikova J; Moserova I; Truxova I; Hermanova I; Vancurova I; Partlova S; Fialova A; Sojka L; Cartron PF; Houska M; Rob L; Bartunkova J; Spisek R
Int J Cancer; 2014 Sep; 135(5):1165-77. PubMed ID: 24500981
[TBL] [Abstract][Full Text] [Related]
6. Calreticulin in phagocytosis and cancer: opposite roles in immune response outcomes.
Schcolnik-Cabrera A; Oldak B; Juárez M; Cruz-Rivera M; Flisser A; Mendlovic F
Apoptosis; 2019 Apr; 24(3-4):245-255. PubMed ID: 30929105
[TBL] [Abstract][Full Text] [Related]
7. Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress.
Martins I; Kepp O; Schlemmer F; Adjemian S; Tailler M; Shen S; Michaud M; Menger L; Gdoura A; Tajeddine N; Tesniere A; Zitvogel L; Kroemer G
Oncogene; 2011 Mar; 30(10):1147-58. PubMed ID: 21151176
[TBL] [Abstract][Full Text] [Related]
8. Biphasic Increases of Cell Surface Calreticulin Following Treatment with Mitoxantrone.
Azuma Y; Suzuki K; Higai K; Matsumoto K; Tada S
Biol Pharm Bull; 2020 Oct; 43(10):1595-1599. PubMed ID: 32727970
[TBL] [Abstract][Full Text] [Related]
9. Ecto-calreticulin in immunogenic chemotherapy.
Obeid M; Tesniere A; Panaretakis T; Tufi R; Joza N; van Endert P; Ghiringhelli F; Apetoh L; Chaput N; Flament C; Ullrich E; de Botton S; Zitvogel L; Kroemer G
Immunol Rev; 2007 Dec; 220():22-34. PubMed ID: 17979837
[TBL] [Abstract][Full Text] [Related]
10. Wogonin induced calreticulin/annexin A1 exposure dictates the immunogenicity of cancer cells in a PERK/AKT dependent manner.
Yang Y; Li XJ; Chen Z; Zhu XX; Wang J; Zhang LB; Qiang L; Ma YJ; Li ZY; Guo QL; You QD
PLoS One; 2012; 7(12):e50811. PubMed ID: 23251389
[TBL] [Abstract][Full Text] [Related]
11. Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference.
Chaput N; De Botton S; Obeid M; Apetoh L; Ghiringhelli F; Panaretakis T; Flament C; Zitvogel L; Kroemer G
J Mol Med (Berl); 2007 Oct; 85(10):1069-76. PubMed ID: 17891368
[TBL] [Abstract][Full Text] [Related]
12. Endoplasmic reticulum stress-mediated membrane expression of CRT/ERp57 induces immunogenic apoptosis in drug-resistant endometrial cancer cells.
Xu Q; Chen C; Lin A; Xie Y
Oncotarget; 2017 Aug; 8(35):58754-58764. PubMed ID: 28938593
[TBL] [Abstract][Full Text] [Related]
13. The n3-polyunsaturated fatty acid docosahexaenoic acid induces immunogenic cell death in human cancer cell lines via pre-apoptotic calreticulin exposure.
Molinari R; D'Eliseo D; Manzi L; Zolla L; Velotti F; Merendino N
Cancer Immunol Immunother; 2011 Oct; 60(10):1503-7. PubMed ID: 21779875
[TBL] [Abstract][Full Text] [Related]
14. Immunogenic cancer cell death: a key-lock paradigm.
Tesniere A; Apetoh L; Ghiringhelli F; Joza N; Panaretakis T; Kepp O; Schlemmer F; Zitvogel L; Kroemer G
Curr Opin Immunol; 2008 Oct; 20(5):504-11. PubMed ID: 18573340
[TBL] [Abstract][Full Text] [Related]
15. Viral strategies for the evasion of immunogenic cell death.
Galluzzi L; Kepp O; Morselli E; Vitale I; Senovilla L; Pinti M; Zitvogel L; Kroemer G
J Intern Med; 2010 May; 267(5):526-42. PubMed ID: 20433579
[TBL] [Abstract][Full Text] [Related]
16. Molecular characteristics of immunogenic cancer cell death.
Tesniere A; Panaretakis T; Kepp O; Apetoh L; Ghiringhelli F; Zitvogel L; Kroemer G
Cell Death Differ; 2008 Jan; 15(1):3-12. PubMed ID: 18007663
[TBL] [Abstract][Full Text] [Related]
17. Phylogenetic conservation of the preapoptotic calreticulin exposure pathway from yeast to mammals.
Madeo F; Durchschlag M; Kepp O; Panaretakis T; Zitvogel L; Fröhlich KU; Kroemer G
Cell Cycle; 2009 Feb; 8(4):639-42. PubMed ID: 19182525
[TBL] [Abstract][Full Text] [Related]
18. Immunogenic cell death modalities and their impact on cancer treatment.
Kepp O; Tesniere A; Schlemmer F; Michaud M; Senovilla L; Zitvogel L; Kroemer G
Apoptosis; 2009 Apr; 14(4):364-75. PubMed ID: 19145485
[TBL] [Abstract][Full Text] [Related]
19. The immunogenicity of tumor cell death.
Kepp O; Tesniere A; Zitvogel L; Kroemer G
Curr Opin Oncol; 2009 Jan; 21(1):71-6. PubMed ID: 19125021
[TBL] [Abstract][Full Text] [Related]
20. Calreticulin regulated intrinsic apoptosis through mitochondria-dependent and independent pathways mediated by ER stress in arsenite exposed HT-22 cells.
Wang X; Liu X; Chen Y; Wang H; Zhang R; Zhang Q; Wei Y; Shi S; Li X
Chemosphere; 2020 Jul; 251():126466. PubMed ID: 32443253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]